A Role for the Epidermal Growth Factor Receptor Signaling in Development of Intestinal Serrated Polyps in Mice and Humansd

被引:28
作者
Bongers, Gerold [1 ]
Muniz, Luciana R. [1 ]
Pacer, Michelle E. [1 ]
Iuga, Alina C. [3 ]
Thirunarayanan, Nanthakumar [1 ]
Slinger, Erik [1 ]
Smit, Martine J. [4 ]
Reddy, E. Premkumar [2 ]
Mayer, Lloyd [1 ]
Furtado, Glaucia C. [1 ]
Harpaz, Noam
Lira, Sergio A. [1 ]
机构
[1] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Dept Pathol, Div Gastrointestinal Pathol, New York, NY 10029 USA
[4] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Fac Sci, Amsterdam, Netherlands
关键词
FACTOR HB-EGF; COLORECTAL-CANCER; TUMOR PROGRESSION; LUNG-CANCER; TUMORIGENESIS; CELLS; DIFFERENTIATION; EXPRESSION; PATHWAY; COLON;
D O I
10.1053/j.gastro.2012.05.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Epithelial cancers can be initiated by activating mutations in components of the mitogen-activated protein kinase signaling pathway such as v-raf murine sarcoma viral oncogene homolog B1 (BRAF), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), or epidermal growth factor receptor (EGFR). Human intestinal serrated polyps are a heterogeneous group of benign lesions, but some progress to colorectal cancer. Tumors that arise from these polyps frequently contain activating mutations in BRAF or KRAS, but little is known about the role of EGFR activation in their development. METHODS: Polyp samples were obtained from adults during screening colonoscopies at Mount Sinai Hospital in New York. We measured levels of EGFR protein and phosphorylation in human serrated polyps by immunohistochemical and immunoblot analyses. We generated transgenic mice that express the ligand for EGFR, Heparin-binding EGF-like growth factor (HB-EGF), in the intestine. RESULTS: EGFR and the extracellular-regulated kinases (ERK)1/2 were phosphorylated in serrated areas of human hyperplastic polyps (HPPs), sessile serrated adenomas, and traditional serrated adenomas. EGFR and ERK1/2 were phosphorylated in the absence of KRAS or BRAF activating mutations in a subset of HPP. Transgenic expression of the EGFR ligand HB-EGF in the intestines of mice promoted development of small cecal serrated polyps. Mice that expressed a combination of HB-EGF and US28 (a constitutively active, G-proteincoupled receptor that increases processing of HB-EGF from the membrane) rapidly developed large cecal serrated polyps. These polyps were similar to HPPs and had increased phosphorylation of EGFR and ERK1/2 within the serrated epithelium. Administration of pharmacologic inhibitors of EGFR or MAPK to these transgenic mice significantly reduced polyp development. CONCLUSIONS: Activation of EGFR signaling in the intestine of mice promotes development of serrated polyps. EGFR signaling also is activated in human HPPs, sessile serrated adenomas, and traditional serrated adenomas. © 2012 AGA Institute.
引用
收藏
页码:730 / 740
页数:11
相关论文
共 45 条
[1]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[2]  
BARNARD JA, 1994, J BIOL CHEM, V269, P22817
[3]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[4]   Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis [J].
Bennecke, Moritz ;
Kriegl, Lydia ;
Bajboubj, Monther ;
Retzlaff, Kristin ;
Robine, Sylvie ;
Jung, Andreas ;
Arkan, Melek C. ;
Kirchner, Thomas ;
Greten, Florian R. .
CANCER CELL, 2010, 18 (02) :135-146
[5]   The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice [J].
Bongers, Gerold ;
Maussang, David ;
Muniz, Luciana R. ;
Noriega, Vanessa M. ;
Fraile-Ramos, Alberto ;
Barker, Nick ;
Marchesi, Federica ;
Thirunarayanan, Nanthakumar ;
Vischer, Henry F. ;
Qin, Lihui ;
Mayer, Lloyd ;
Harpaz, Noam ;
Leurs, Rob ;
Furtado, Glaucia C. ;
Clevers, Hans ;
Tortorella, Domenico ;
Smit, Martine J. ;
Lira, Sergio A. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11) :3969-3978
[6]   V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a [J].
Carragher, Linda A. S. ;
Snell, Kimberley R. ;
Giblett, Susan M. ;
Aldridge, Victoria S. S. ;
Patel, Bipin ;
Cook, Simon J. ;
Winton, Doug J. ;
Marais, Richard ;
Pritchard, Catrin A. .
EMBO MOLECULAR MEDICINE, 2010, 2 (11) :458-471
[7]   Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes [J].
Chen, Chun-Liang ;
Mehta, Veela B. ;
Zhang, Hong-Yi ;
Wu, Dana ;
Otabor, Iyore ;
Radulescu, Andrei ;
El-Assal, Osama N. ;
Feng, Jiexiong ;
Chen, Yan ;
Besner, Gail E. .
GROWTH FACTORS, 2010, 28 (02) :82-97
[8]   Drug therapy: EGFR antagonists in cancer treatment [J].
Ciardiello, Fortunato ;
Tortora, Giampaolo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11) :1160-1174
[9]   United States Food and Drug Administration drug approval summary: Gefitinib (ZD1839; Iressa) tablets [J].
Cohen, MH ;
Williams, GA ;
Sridhara, R ;
Chen, G ;
McGuinn, WD ;
Morse, D ;
Abraham, S ;
Rahman, A ;
Liang, CY ;
Lostritto, R ;
Baird, A ;
Pazdur, R .
CLINICAL CANCER RESEARCH, 2004, 10 (04) :1212-1218
[10]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867